FindMyKOL
Clinical trialNCT01742208CompletedPhase 2Interventional

Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus

SponsorLexicon PharmaceuticalsEnrollment36Type 1 Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This Phase 2 study was intended to assess the pharmacodynamics (PD), pharmacokinetics (PK), safety and efficacy of sotagliflozin following daily oral administration for 29 days in participants with type 1 diabetes mellitus (T1DM).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Lexicon Investigational Site

    Aurora, Colorado, United States

  • Lexicon Investigational Site

    Atlanta, Georgia, United States

  • Lexicon Investigational Site

    Baton Rouge, Louisiana, United States

  • Lexicon Investigational Site

    Omaha, Nebraska, United States

  • Lexicon Investigational Site

    The Bronx, New York, United States

  • Lexicon Investigational Site

    Durham, North Carolina, United States

  • Lexicon Investigational Site

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboSotagliflozin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2013
Primary completion
31 Jan 2014
Completion
31 Jan 2014
Last update posted
12 Feb 2020
Registered enrollment
36
Registry id
NCT01742208
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.